Add BrightSurf on Google Email

Science News Archive 2026 - Page 95


Page 95 of 493

“Overwhelmingly positive” results reported with a virtual e-health system (VIRTUES) to monitor cardiac implantable electronic devices

A virtual e-health system (VIRTUES) has been found to be as safe and effective as standard care for monitoring cardiac implantable electronic devices, with significant cost savings and patient satisfaction. The system uses transmission reports from the patient's device to provide real-time monitoring and communication with the physician.

Remote exercise-based cardiac rehabilitation − an additional option but not a replacement for centre-based rehabilitation

Remote exercise-based cardiac rehabilitation shows promise as an additional option for patients, but does not replace centre-based rehabilitation. The study found that remotely delivered exercise improved physical capacity and was used by a substantial proportion of patients, despite not increasing overall participation.

REACT reveals that silent atherosclerosis already affects 1 in 13 young adults aged 18 to 29 and progresses rapidly from the menopause

The REACT study reveals that 57.1% of participants aged 18 to 70 had atherosclerotic plaques, despite no symptoms or previous diagnosis. Most people with coronary atherosclerosis also had the disease in other arteries, making portable ultrasound devices a promising screening tool.

Cholesterol-lowering medication reduces major cardiovascular events by 30% in older people without known cardiovascular disease

A new study found that atorvastatin reduces major cardiovascular events by 30% in people aged 70 and older without known cardiovascular disease, diabetes, or dementia. However, it did not improve disability-free survival. The results inform treatment guidelines for older adults, who are underrepresented in previous trials.

Monoclonal antibody targeting interleukin-6 achieves sustained reductions in inflammation biomarkers through six months

A phase 2 clinical trial found that a monoclonal antibody targeting interleukin-6 achieved sustained reductions in inflammation biomarkers for six months in patients with chronic kidney disease. The therapy, known as pacibekitug, was well-tolerated and showed favorable effects on additional biomarkers associated with cardiovascular risk.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·TypeRandomized controlled/clinical trial·DateAug 29, 2026

LDL cholesterol lowering with evolocumab before percutaneous coronary intervention for acute myocardial infarction (AMUNDSEN)

Starting evolocumab before or during percutaneous coronary intervention for acute myocardial infarction significantly reduces LDL cholesterol levels. However, this strategy does not improve short-term clinical outcomes, including death and cardiovascular hospitalization, during the first year. The study suggests that lowering LDL chole...

SourceJAMA Network·JournalJAMA·DateAug 29, 2026

Intensified antiplatelet therapy plus direct oral anticoagulants increased bleeding in patients with atrial fibrillation after a heart attack

Atrial fibrillation patients who have had a heart attack may be at increased risk of bleeding if given potent antiplatelet therapy combined with direct oral anticoagulants. The EPIDAURUS trial found no significant benefits regarding cardiovascular events, suggesting these treatments may not be necessary for this patient population.

Reading the giant tortoise DNA that time forgot

Researchers at Yale University have discovered two ancient, extinct giant tortoise lineages using a new combination of computational tools. The findings can aid conservation efforts in the Galapagos archipelago by unlocking the genetic diversity of extinct species.

SourceYale University·JournalProceedings of the Royal Society B Biological Sciences·DateAug 28, 2026

New guidelines aim to bring precision medicine to stroke rehabilitation

Researchers developed new guidelines to study molecular biomarkers associated with stroke recovery. The recommendations aim to identify biological signals that can help clinicians determine the most effective therapies for each patient at the right moment. The guidelines also emphasize the importance of creating national biomarker cent...

SourceUniversity of Maryland School of Medicine·JournalInternational Journal of Stroke·TypeSystematic review·DateAug 28, 2026

Paving the way to critical minerals

Researchers at Texas A&M University are working on a project to develop a mobile and efficient drilling system that combines faster drilling technology, real-time rock analysis, and artificial intelligence to identify valuable minerals in real time. This project aims to reduce the time needed to evaluate potential deposits of rare eart...

RESEARCH: Fast fashion’s carbon footprint can be reduced across its life cycle, new Concordia study suggests

A new Concordia study suggests that reducing fast fashion's environmental impact can be achieved through changes in manufacturing, transportation, and consumer use. By producing fewer garments, designing them with longevity in mind, and cutting back on air freight, the fashion industry can achieve significant environmental benefits.

SourceConcordia University·JournalCleaner Waste Systems·TypeComputational simulation/modeling·DateAug 28, 2026

Nearly 1 in 5 Medicaid-eligible adults in expansion states are at risk of losing health coverage due to insufficient or inconsistent work hours

A new study found that nearly 20% of eligible adults in Medicaid expansion states are at risk of losing health coverage due to insufficient or inconsistent work hours. Women, unmarried people, and those with limited education are disproportionately affected.

SourceBoston University School of Public Health·JournalJAMA Health Forum·TypeObservational study·DateAug 28, 2026

Next generation theranostic pair offers new strategy to detect and treat metastatic kidney cancer

A new theranostic pair, 68Ga/177Lu-NYM096, shows excellent tumor uptake in clear cell renal cell carcinoma lesions and demonstrates early evidence of tumor response in patients. The radiotracer can identify tumors and deliver targeted radiotherapy, mitigating toxicity issues common with treatment.

SourceSociety of Nuclear Medicine and Molecular Imaging·JournalJournal of Nuclear Medicine·DateAug 28, 2026

JMIR news: Digital tools changing our health landscape

Digital tools are transforming clinical research, public health readiness, healthcare institutions, and consumer choices. Citizen science initiatives using mobile apps are also growing, with three types of citizen science identified: with-the-people, by-the-people, and for-the-people.

SourceJMIR Publications·JournalJournal of Medical Internet Research·TypeNews article·DateAug 28, 2026

ISB researchers identify immune cells that drive harmful autoantibody responses after COVID-19

Researchers have identified a subset of B cells known as atypical memory cells as the primary precursors of autoantibody-producing cells during SARS-CoV-2 infection. These cells adopt a markedly different biological program, leading to increased autoantibody production. The study provides new insight into how viral infections can trigg...

SourceInstitute for Systems Biology·JournalImmunity·DateAug 28, 2026

“HOPE” to reign in a crisis

A new generation of intelligent decision support methods and software tools will be developed to enhance supply chain resilience, optimize healthcare operations, and strengthen emergency response coordination. The HOPE project aims to create a lasting area of excellence in human-centered AI, serving as a trusted partner for government,...